BIOPitch and Investor Participation

BIOPitch and Investor Participation

BIOPitch and Investor Participation 150 150 adjuvant-admin

Fort Lauderdale – October 8, 2018 – On behalf of BioFlorida, an investor committee has selected 16 seed and early-stage life science companies to compete during BioPitch at the BioFlorida Conference taking place October 14-16 at The Westin Fort Lauderdale Beach Resort in Fort Lauderdale, FL.

The companies will present to investors during a closed-door session on the afternoon of Monday, October 15. Four selected finalists will present during the Tuesday morning session to a panel of investors, and the winner will be announced at the close of the session.

BioPitch Committee Co-Chair: Jane E. Teague, Institute for Commercialization of Florida Technology
BioPitch Committee Co-Chair: Valerie McDevitt, JD, University of South Florida

CONGRATULATIONS TO OUR SELECTED COMPANIES!

Antibiotic Adjuvant (Gainesville)

Aventusoft (Boca Raton)

Celigenex (Fort Lauderdale)

Dalent Medical (Coral Gables)

HealthSteps (Gainesville)

KynderMed (Tallahassee)

M:14;22-33 (Gainesville)

Moterum Technologies (Seneca, SC)

Nutent Therapeutics (Boca Raton)

RashEndZ (St. Petersburg)

Resility Health (Jacksonville)

Simple Foods Collaborative Company

(Hallandale Beach)

STAT3 Therapeutics (Coral Springs)

Stuart Therapeutics (Stuart)

ThNA BioSciences (TAMPA)

Vestion (Miami)

INVESTORS PARTICIPATING IN BIOPITCH

  • Todd Andersen-Davis | Florida Technology Seed Capital Fund  
  • Marc Blumenthal | Florida Funders
  • Nathan Cali | NOBLE Life Science Partners
  • Tom Cardy | New World Angels
  • Tim Cartwright | Tamiami Angel Fund
  • Kathy Chiu | FAN Fund  
  • Tom Gardner | Bridge Angel Investors
  • Steve Glover | Asclepius Lifesciences / Variant
  • Kunal Jain | TiE Tampabay Angel Fund I L.P.
  • Brian M. Koslow | DWBK Partners LLC  
  • Orin Levy | Angel Investor
  • Peter Livingston | Angel Investor
  • Ben Scruggs | Hatteras Venture Partners
  • Jackson Streeter, MD | Institute for Commercialization of Florida Technology
  • John Tullis | Tullis Funds
  • Harry Venezia, Jr. | Healthcare Capital Advisors

MENTORING FOR OUR BIOPITCH COMPANIES PROVIDED BY

Leave a Reply